Bluejay DiagnosticsBJDX
13F holders, Q2 2026 (June 30)8holders +2
5new positions
3sold out
$1.20avg. 13F price*
At the end of Q2 2026, 8 institutions reported holding Bluejay Diagnostics Inc. (BJDX) in their 13F filings, up 2 from Q1 2026. 5 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($157K), Heights Capital Management, Inc. ($42K) and Boothbay Fund Management, LLC ($33K).
- Company
- Bluejay Diagnostics Inc.
- CUSIP
- 095633608
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $257K |
| Exits | 3 | $105K |
All 13F filers, Q1 2026 → Q2 2026: 214,270 shares bought and 56,979 shares sold, net +157,291 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Armistice Capital, LLC | 0.00% | New | 131,000 | $157K |
| Heights Capital Management, Inc. | 0.01% | New | 35,400 | $42K |
| Boothbay Fund Management, LLC | 0.00% | New | 27,130 | $33K |
| Bank of America Corp. | 0.00% | New | 10,337 | $12K |
| Vanguard Fiduciary Trust Co. | 0.00% | New | 10,225 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +10.3% | 1,907 | $2K |
| L1 Global Manager Pty Ltd | 0.00% | No change | 120 | $144 |
| Caitong International Asset Management Co., Ltd | 0.00% | Reduce -66.7% | 1 | $1 |
"% of holder's portfolio" is BJDX's weight in each manager's 13F, not the share of Bluejay Diagnostics Inc. the manager owns.